Pediatric CRISPR Therapy for Sickle Cell and Beta-Thalassemia with Dr. Haydar Frangoul, MD

Name: Pediatric CRISPR Therapy for Sickle Cell and Beta-Thalassemia with Dr. Haydar Frangoul, MD
Start: 2026-11-12T22:00:00+00:00
End: 2026-11-12T23:30:00+00:00
Location: FCOM 2201

Make a free account to save this and get a reminder before it starts.Sign up

When: Thursday, November 12, 20264:00 PM – 5:30 PM CSTAdd to calendar Google Calendar
Where: FCOM 2201Open in Maps
Hosted by: FCoM Journal Club

Reminders arrive as notifications from the NextToU iPhone app. Get the app

Academic & StudyClubs & Orgs

About

Journal Club's first meeting of the year will be with Dr. Haydar Frangoul from the Sarah Cannon Institute at Tristar Centennial, who has been an integral part of gaining FDA approval for Casgevy, expanding treatment options for children with sickle cell anemia and transfusion-dependent beta-thalassemia.

Open the original listing